<DOC>
	<DOCNO>NCT00000127</DOCNO>
	<brief_summary>To assess safety efficacy optic nerve sheath decompression surgery non-arteritic ischemic optic neuropathy ( NAION ) .</brief_summary>
	<brief_title>Ischemic Optic Neuropathy Decompression Trial ( IONDT )</brief_title>
	<detailed_description>Non-arteritic ischemic optic neuropathy ( NAION ) , common cause acute optic nerve disease old person , cause permanent severe visual loss . Visual function impair decreased central visual acuity peripheral field loss , . NAION strike eye 40 percent affect patient . The incidence NAION estimate 2.3 per 100,000 person age 50 year 0.54 per 100,000 age . Estimates number new case see year United States range low approximately 1,500 high 6,000 . NAION hypothesize cause vascular insufficiency lead optic nerve head ischemia . There general agreement NAION result transient non-perfusion nutrient vessel . The wide range visual field defect visual loss NAION explain extent number blood vessel involve . Anatomical factor appear contribute vascular event initiate NAION . Clinically , number disc congenitally lack physiological cup eye NAION higher expect . Presumably , eye NAION , discs small scleral opening crowd nerve fiber pass restrict space optic disc lamina cribrosa , thereby predispose ischemic spiral . One current theory hold NAION begin minor ischemic event later progress major infarction due congenitally anomalous optic nerve . The incite ischemic event lead local anterior nerve edema , cause ischemia . Optic nerve sheath decompression surgery report 1989 benefit patient NAION . The presumed mechanism action optic nerve decompression surgery revolve around restoration impair blood flow optic nerve reduction pressure around nerve . The Ischemic Optic Neuropathy Decompression Trial ( IONDT ) randomize clinical trial design compare improvement visual acuity 6 month patient assign receive surgery optic nerve sheath decompression assign careful followup . A cohort patient , baseline visual acuity well 20/64 also follow good understand natural history disease , include second eye involvement . Enrollment begin October 1992 . Randomization stratify clinic , patient equal probability assignment surgery careful followup . All patient follow minimum 2 year . The primary outcome change three line visual acuity 6-month followup visit compare visual acuity measure randomization visit . Secondary outcome include change visual acuity beyond 6 month , change peripheral visual function measure automate Humphrey perimetry , local systemic side effect treatment , change quality life , associate morbidity mortality .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Neuropathy , Ischemic</mesh_term>
	<criteria>Men woman age 50 year old , acute NAION visual symptom 14 day less since onset symptom , visual acuity bad equal 20/64 eligible randomization .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Non-arteritic Ischemic Optic Neuropathy</keyword>
</DOC>